Filter Results:
(2,412)
Show Results For
- All HBS Web
(2,412)
- People (5)
- News (272)
- Research (1,920)
- Events (6)
- Multimedia (1)
- Faculty Publications (996)
Show Results For
- All HBS Web
(2,412)
- People (5)
- News (272)
- Research (1,920)
- Events (6)
- Multimedia (1)
- Faculty Publications (996)
- June 1994 (Revised June 1995)
- Case
Chandler Home Products: European Rationalization
Chandler, a large U.S. consumer products firm, is rationalizing its European operations. Tony Pesci, protagonist, is deciding which plants to close for maximum efficiency. The manufacturing/marketing relationship is strained as efficiency is being weighed against... View Details
Keywords: Debates; Cross-Cultural and Cross-Border Issues; Labor; Contracts; Operations; Performance Efficiency; Relationships; Consumer Products Industry; United States
Yoshino, Michael Y. "Chandler Home Products: European Rationalization." Harvard Business School Case 394-221, June 1994. (Revised June 1995.)
- March 2014
- Case
Milk Baths and Charm Necklaces: Had Randy Weiner (Finally) Gone Too Far?
By: Mukti Khaire and Hannah Catzen
The case on Randy Weiner explores the tensions between artistic and financial imperatives in a for-profit immersive theater venture. In order to revive the dormant Manhattan nightclub "The Diamond Horseshoe," theater-impresario Randy Weiner created "The Queen of the... View Details
Khaire, Mukti, and Hannah Catzen. "Milk Baths and Charm Necklaces: Had Randy Weiner (Finally) Gone Too Far?" Harvard Business School Case 814-079, March 2014.
- 2008
- Chapter
Where is the Pharmacy to the World? Pharmaceutical Industry Location and International Regulatory Variation
By: Arthur A. Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater... View Details
Keywords: Geographic Location; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Demand and Consumers; Pharmaceutical Industry; European Union; Germany; United States
Daemmrich, Arthur A. "Where is the Pharmacy to the World? Pharmaceutical Industry Location and International Regulatory Variation." Chap. 16 in Ways of Regulating: Therapeutic Agents between Plants, Shops, and Consulting Rooms. Vol. 363, edited by Jean Paul Gaudillière and Volker Hess, 271–290. Berlin, Germany: Max-Planck-Institut für Wissenschaftsgeschichte, 2008.
- 2013
- Working Paper
The Dirty Laundry of Employee Award Programs: Evidence from the Field
By: Timothy Gubler, Ian I. Larkin and Lamar Pierce
Many scholars and practitioners have recently argued that corporate awards are a "free" way to motivate employees. We use field data from an attendance award program implemented at one of five industrial laundry plants to show that awards can carry significant... View Details
Keywords: Motivation and Incentives; Service Delivery; Performance Productivity; Failure; Service Industry
Gubler, Timothy, Ian I. Larkin, and Lamar Pierce. "The Dirty Laundry of Employee Award Programs: Evidence from the Field." Harvard Business School Working Paper, No. 13-069, February 2013.
- 2009
- Working Paper
Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
By: Arthur Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Health Testing and Trials; Power and Influence; Competitive Strategy; Pharmaceutical Industry; European Union; Germany; United States
Daemmrich, Arthur. "Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location." Harvard Business School Working Paper, No. 09-118, April 2009.
- 09 Feb 2007
- Working Paper Summaries
Do Corporate Social Responsibility Ratings Predict Corporate Social Performance?
- Program
Behavioral Economics—Virtual
outcomes for your company. Details Understand the actions of your customers and employees Discover the subtle forces driving choices and become your organization's go-to problem-solver Develop a user-oriented, outcome-driven mindset Improve employee motivation Design... View Details
- 18 Apr 2013
- Working Paper Summaries
The Impact of Pooling on Throughput Time in Discretionary Work Settings: An Empirical Investigation of Emergency Department Length of Stay
- February 1985 (Revised July 1986)
- Case
Applichem (A)
Applichem has six plants in different countries making the same chemical product. The purpose of this case is to allow students to think about what costs are relevant to management in this process industry environment, about how to define a comparison of costs and... View Details
Keywords: Business or Company Management; Multinational Firms and Management; Performance Productivity; Operations; Performance Improvement; Chemical Industry
Flaherty, Marie-Therese M. "Applichem (A)." Harvard Business School Case 685-051, February 1985. (Revised July 1986.)
- Web
Faculty & Advisors | MBA
capital fund that has been building an in-house AI platform for the past decade with $2B+ AUM. Prior to SignalFire, she was a product leader at CVS Health, where she launched nationwide prescription delivery and virtual care products, and... View Details
- Article
To Drive Efforts...Don't Tiptoe Around Your Legal Risk
By: Edward Chang and Bonnie Levine
Many Diversity, Equity, and Inclusion (DEI) initiatives are scuttled because DEI leaders and legal teams feel themselves to be at odds over questions of acceptable risk. DEI leaders see lawyers as guardians of the status quo, whereas legal experts, trained to... View Details
Chang, Edward, and Bonnie Levine. "To Drive Efforts...Don't Tiptoe Around Your Legal Risk." Harvard Business Review 100, no. 4 (July–August 2022): 74–81.
- Article
Optimizing Organic Waste to Energy Operations
By: Baris Ata, Deishin Lee and Mustafa H. Tongarlak
A waste-to-energy firm that recycles organic waste with energy recovery performs two environmentally beneficial functions: it diverts waste from landfill and it produces renewable energy. At the same time, the waste-to-energy firm serves and collects revenue from two... View Details
Keywords: Business Ventures; Energy Generation; Renewable Energy; Revenue; Customers; Strategy; Corporate Governance; Wastes and Waste Processing; Environmental Sustainability; Governing Rules, Regulations, and Reforms; Cost Management; Urban Scope
Ata, Baris, Deishin Lee, and Mustafa H. Tongarlak. "Optimizing Organic Waste to Energy Operations." Manufacturing & Service Operations Management 14, no. 2 (Spring 2012): 231–244.
- April 2020
- Supplement
Luvo (B)
By: José B. Alvarez and Natalie Kindred
This case, a follow on to HBS No. 517-049 "Luvo," provides a brief look at changes that have occurred at Luvo, now called Performance Kitchen, since the timing of the first case (mid-2016). Set in January 2020, “Luvo (B)” touches on developments such as the company's... View Details
Keywords: Consumer Behavior; Health; Health Care and Treatment; Nutrition; Food; Strategy; Product Positioning; Product Marketing; Consumer Products Industry; Consumer Products Industry; Consumer Products Industry; Consumer Products Industry; United States; Canada
Alvarez, José B., and Natalie Kindred. "Luvo (B)." Harvard Business School Supplement 520-101, April 2020.
- February 1996 (Revised April 2004)
- Case
Eli Lilly and Company: Innovation in Diabetes Care
By: Clayton M. Christensen
Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the... View Details
Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry
Christensen, Clayton M. "Eli Lilly and Company: Innovation in Diabetes Care." Harvard Business School Case 696-077, February 1996. (Revised April 2004.)
- 2008
- Book
Managing Your Boss
By: John J. Gabarro and John P. Kotter
Managing your boss: Isn't that merely manipulation? Corporate cozying up? Not according to John Gabarro and John Kotter. In this handy guidebook, the authors contend that you manage your boss for a very good reason: to do your best on the job—and thereby benefit not... View Details
Keywords: Communication; Decision Making; Information Management; Managerial Roles; Negotiation Tactics; Performance Productivity; Personal Development and Career; Relationships; Personal Characteristics
Gabarro, John J., and John P. Kotter. Managing Your Boss. Paperback ed. Harvard Business Review Classics. Harvard Business School Press, 2008.
- 09 Jan 2018
- Working Paper Summaries
Identifying Sources of Inefficiency in Health Care
- November 2009 (Revised March 2013)
- Case
PureCircle
By: David E. Bell and Aldo Sesia
In December 2008, the U.S. Food and Drug Administration (FDA) determined that high-purity Rebaudioside A (Reb A), a natural and calorie-free product that a young company named PureCircle manufactured from the Stevia plant, could be used in beverages, foods, and as a... View Details
Keywords: Customer Relationship Management; Investment; Globalization; Leadership; Risk Management; Product Launch; Production; Performance Productivity; Business and Shareholder Relations; Food and Beverage Industry; United States
Bell, David E., and Aldo Sesia. "PureCircle." Harvard Business School Case 510-032, November 2009. (Revised March 2013.)
- October 2001 (Revised March 2008)
- Case
Anagene, Inc.
By: Robert S. Kaplan and Christina L. Darwall
An entrepreneurial, publicly traded biotech company has begun production and sales of its core product--cartridges that permit DNA samples to be analyzed on a microchip. In the early quarters, sales are difficult to forecast and the company has experienced fluctuating... View Details
Keywords: Cost Accounting; Financial Reporting; Production; Performance Capacity; Risk and Uncertainty; Genetics; Governing and Advisory Boards; Biotechnology Industry; California
Kaplan, Robert S., and Christina L. Darwall. "Anagene, Inc." Harvard Business School Case 102-030, October 2001. (Revised March 2008.)
- 26 Jul 2006
- Research & Ideas
The Strategic Way to Go to Market
repository of lost opportunities" that serve neither end users nor channel partners very well. Why is this? A: That is because most channels are constructed from the supplier out, rather than from the customer in. In other words, the View Details
Keywords: by Sean Silverthorne
- May 2024 (Revised February 2025)
- Case
Lowe's: Improving the Total Home Strategy
By: Elie Ofek, K. Shelette Stewart and Alicia Dadlani
In 2023, Marvin Ellison, CEO of Lowe’s, contemplated enhancements to the company’s Total Home Strategy to accelerate performance and grow market share. In the last five years since becoming CEO, Ellison had championed a turnaround of the company, completing a... View Details
Keywords: Growth and Development Strategy; E-commerce; Competition; Brands and Branding; Business Strategy; Retail Industry; United States; North Carolina
Ofek, Elie, K. Shelette Stewart, and Alicia Dadlani. "Lowe's: Improving the Total Home Strategy." Harvard Business School Case 524-054, May 2024. (Revised February 2025.)